| 2,476 | 20 | 97 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:采用网络药理学-分子对接的方法,探讨黄芪桂枝五物汤预防运动性疲劳(Exercise-induced fatigue, EF)的作用机制,并进行动物实验验证分析。方法:通过网络药理学工具获得黄芪桂枝五物汤预防EF的有效成分、核心靶点和信号通路。构建EF大鼠模型,进行HE染色、ELISA、PCR法验证网络药理学预测的主要靶点及预防效果。结果:筛选出黄芪桂枝五物汤中43个活性成分和242个潜在靶点,运动性疲劳潜在靶点1 002个;药物和疾病交集靶点104个,包括AKT1、IL6、TNF、IL1B、PPARG、PTGS2等。KEGG富集分析结果包括AGE-RAGE信号通路、TNF信号通路、IL-17信号通路、HIF-1信号通路等;分子对接结果显示豆甾醇、刺芒柄花素及原阿片碱等活性成分与PTGS2、PTGS1、CHRM1等关键靶点表现出良好的对接活性,黄芪桂枝五物汤可能通过影响AKT1、IL-6、TNF、IL-1B、PPARG、PTGS2等靶蛋白的表达进而调控炎症反应和细胞凋亡。黄芪桂枝五物汤可以使大鼠肌纤维排列更紧密,增强大鼠四肢肌力、运动耐力、心脏供血能力,且缓解心脏过度代偿。与正常对照组比较,模型对照组游泳力竭时间与四肢抓力显著减少,血清中肌酸激酶(CK)、血乳酸(BLA)、白介素6(IL-6)、肿瘤坏死因子(TNF-α)、缺氧诱导因子(HIF-1α)的含量显著升高,血管内皮生长因子(VEGF)与促红细胞生成素(EPO)的含量显著降低(P<0.01),雌激素受体1(Esr1)表达下调,前列腺素内过氧化物合酶2(Ptgs2)、蛋白激酶1(Akt1)、过氧化物酶体增殖物激活受体γ(Pparg)和果寡糖(Fos)mRNA表达上调(P<0.05);与模型对照组比较,黄芪桂枝五物汤组游泳力竭时间与四肢抓力显著增加,血清中CK、BLA、IL-6、TNF-α、HIF-1α的含量显著减少;VEGF、EPO的含量显著增加(P<0.01);Esr1 mRNA表达上调,Ptgs2、Akt1、Pparg、Fos mRNA表达下调(P<0.05)。结论:黄芪桂枝五物汤中槲皮素、β-谷甾醇、山柰酚等化合物发挥核心作用,通过影响PTGS2、PTGS1、ADRB2等靶蛋白的表达并参与AGE-RAGE、TNF、IL-17信号传导途径,发挥预防运动性疲劳的作用。
Abstract:Objective:To investigate the mechanism of action of Huangqi Guizhi Wuwu(黄芪桂枝五物) Decoction in the treatment of exercise-induced fatigue(EF) by using network pharmacology and molecular docking, and to validate and analyze it through animal experiments. Methods:The active ingredients, core targets and signaling pathways of Huangqi Guizhi Wuwu Decoction in the treatment of EF were obtained by network pharmacology tools. An EF rat model was constructed, and HE staining, ELISA,and PCR experiments were performed to verify the principal targets and therapeutic effects predicted by network pharmacology. Results:A total of 43 active ingredients and 242 potential targets in Huangqi Guizhi Wuwu Decoction were screened out, and 1002 potential targets for EF. A total of 104 targets was observed at the intersection of drug and disease, including AKT1,IL6,TNF,IL1B,PPARG,PTGS2,etc. The results of KEGG enrichment analysis showed that AGE-RAGE,TNF,IL-17,TNF,IL-17and HIF-1 signaling pathways were involved. The molecular docking results showed that the active ingredients, such as leguminol, prickly aristolochicin and proto-opiomelanocarpine hadgood binding activities with key targets, such as PTGS2,PTGS1,CHRM1,etc. Huangqi Guizhi Wuwu Decoction affected the expression of target proteins, such as AKT1,IL-6,TNF,IL-1B,PPARG,PTGS2,etc.,and thus regulated inflammatory response and apoptosis. Animal experiment results showed that Huangqi Guizhi Wuwu Decoction could induce rat muscle fibers more closely aligned, enhance rat limb muscle strength, exercise endurance, cardiac blood supply, and alleviate the cardiac overcompensation. Compared with the control group, the swimming exhaustion time and limb grip strength were significantly reduced in the model group. The serum levels of creatine kinase(CK),blood lactate(BLA),interleukin 6(IL-6),tumor necrosis factor-α(TNF-α),and hypoxia-inducible factor-1α(HIF-1α) were significantly elevated. The levels of vascular endothelial growth factor(VEGF) and erythropoietin(EPO) were significantly reduced(P<0.01). The mRNA expression of estrogen receptor 1(ESR1) was down regulated, and the mRNA expressions of prostaglandin endometriosis synthase 2(Ptgs2),threonine kinase 1(Akt1),peroxisome proliferator-activated receptor γ(Pparg),and fructooligosaccharides(Fos) were up regulated(P<0.05). Compared with the model group, the swimming exhaustion time and limb grip strength was significantly increased in the Huangqi Guizhi Wuwu Decoction group, the serum levels of BLA,CK,IL-6,TNF-α,and HIF-1α were significantly decreased, and the levels of VEGF and EPO were significantly increased(P<0.01). The mRNA expression of Esr1 was up regulated, while the mRNA expressions of Ptgs2,Akt1,Pparg,and Fos were down regulated(P<0.05). Conclusion:Quercetin, β-sitosterol, kaempferol and other compounds in Huangqi Guizhi Wuwu Decoction played a key role in the prevention and treatment of EF by affecting the expression of target proteins, such as PTGS2,PTGS1 and ADRB2,and participating in the signaling pathways, such as AGE-RAGE,TNF and IL-17 signaling pathways.
[1]贾瑞真,姜超,金其贯,等.左旋肉碱、泛酸、辅酶Q10联合干预有氧运动疲劳模型小鼠的作用及机制[J].中国组织工程研究,2022,26(2):165-170.
[2]ZHANG H,ZHAO C,HOU J,et al.Red ginseng extract improves skeletal muscle energy metabolism and mitochondrial function in chronic fatigue mice[J].Front Pharmacol,2022,13:1077249.
[3]Sandler C X,Lloyd A R.Chronic fatigue syndrome:progress and possibilities[J].Med J Aust,2020,212(9):428-433.
[4]王明明,张红娟.运动性疲劳的中医生理整体观[J].中国运动医学杂志,2015,34(12):1211-1214,1219.
[5]李慧,高明,周荣杰,等.中医药治疗运动性疲劳研究热点可视化分析[J].中国中医药信息杂志,2023,30(10):81-88.
[6]朱欢,晋宇,田广,等.高压氧在运动科学领域中的应用研究进展[J].中国运动医学杂志,2022,41(7):567-575.
[7]张星耀,谢宗立.黄芪桂枝五物汤治验举隅[J].时珍国医国药,2001,(1):28.
[8]董佳安,刘汝银,岳宗进,等.黄芪桂枝五物汤减弱椎间盘终板软骨细胞线粒体损伤和氧化应激[J].中国组织工程研究,2023,27(32):5137-5143.
[9]国家中医药管理局,国家药品监督管理局.关于发布《古代经典名方关键信息考证原则》《古代经典名方关键信息表(7首方剂)》的通知[EB/OL].(2020-11-11)[2023-10-29].https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20201111091109170.html.
[10]Trott O,Olson A J.AutoDock Vina:improving the speed and accuracy of docking with a new scoring function,efficient optimization,and multithreading[J].J Comput Chem,2010,31(2):455-461.
[11]赵赫然,周毅,陈雷雷,等.基于网络药理学和体内实验研究黄芪桂枝五物汤治疗痛风性关节炎的分子机制[J].中药药理与临床,2022,38(4):14-21.
[12]冉清智,徐艳,何本祥,等.艾灸"足三里"、"关元"对模拟低住高练大鼠诱导缺氧因子和有氧运动能力的影响[J].现代生物医学进展,2022,22(18):3413-3419.
[13]LIU Y,LI C,SHEN X,et al.The use of traditional Chinese medicines in relieving exercise-induced fatigue[J].Front Pharmacol,2022,13:969827.
[14]李傲霜,郑慧娟,冉清智,等.雷公藤制剂联合中医药治疗慢性肾脏病安全性的Meta分析[J].世界中西医结合杂志,2023,18(12):2344-2353.
[15]冉清智,陈恒文,李傲霜.荷丹片治疗血脂异常的研究进展[J].中西医结合心脑血管病杂志,2023,21(19):3544-3549.
[16]Twomey R,Aboodarda S J,Kruger R,et al.Neuromuscular fatigue during exercise:Methodological considerations,etiology and potential role in chronic fatigue[J].Neurophysiol Clin,2017,47(2):95-110.
[17]王桂彬,庞博,朴炳奎.“劳者温之”内涵考镜[J].北京中医药大学学报,2023,46(2):191-195.
[18]林致辉,刘宏岩.中药抗运动性疲劳的研究现状[J].吉林中医药,2019,39(10):1394-1396.
[19]吕琴,赵文晓,王世军,等.黄芪活血功效及现代药理学研究进展[J].中国实验方剂学杂志,2020,26(9):215-224.
[20]ZHENG K Y,Choi R C,Cheung A W,et al.Flavonoids from Radix Astragali induce the expression of erythropoietin in cultured cells:a signaling mediated via the accumulation of hypoxia-inducible factor-1α[J].J Agric Food Chem,2011,59(5):1697-1704.
[21]张英,李铁兵.参芪合剂抗疲劳作用的基础与临床研究[J].中医药学报,1998,(4):36.
[22]杨山景,封安杰,孙越,等.白芍总苷的药理作用及机制研究进展[J].中国现代应用药学,2021,38(13):1627-1633.
[23]裘淼,熊中奎,吕梦宇.大枣多糖的药理作用研究进展[J].中国现代医生,2018,56(22):161-164.
[24]王欢欢,孔巧丽,郭琴,等.生姜的古代文献沿革分析及现代药理研究进展[J].中药新药与临床药理,2021,32(10):1582-1590.
[25]侯文,卢建森,左怀文,等.熊果酸通过调控PTGS2对小鼠肝缺血/再灌注损伤的保护作用[J].实用器官移植电子杂志,2022,10(4):353-359.
[26]池宁娟,刘明义,冯娟,等.如意金黄贴对良性前列腺增生大鼠TGFβ1、PTGS2 mRNA及相关蛋白的影响[J].中国老年学杂志,2022,42(19):4831-4834.
[27]Popovics P,Awadallah W N,Kohrt S E,et al.Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia[J].Prostate,2020,80(10):731-741.
[28]WANG Y,LIU Y,ZHANG M,et al.Inhibition of PTGS1 promotes osteogenic differentiation of adipose-derived stem cells by suppressing NF-kB signaling[J].Stem Cell Res Ther,2019,10(1):57.
[29]JI L,XU F,ZHANG J,et al.ADRB2 expression predicts the clinical outcomes and is associated with immune cells infiltration in lung adenocarcinoma[J].Sci Rep,2022,12(1):15994.
[30]冉清智,陈晶晶,肖雪,等.“武医宗师”郑怀贤伤科学术思想撮要[J].中国民间疗法,2022,30(24):40-42.
[31]齐凤军,王宗佼,代瑜,等.推拿背腰部膀胱经穴对慢性疲劳综合征患者血清IL-6、CHRM1含量的影响及临床疗效观察[J].湖北中医药大学学报,2020,22(3):63-66.
[32]陈晓凤.胆碱能抗炎通路对大鼠缺血再灌注心肌基因表达的影响[D].中南大学,2009.
[33]陈纪烨,张永健,姜萍,等.基于网络药理学的五苓散治疗慢性心力衰竭的机制研究[J].中草药,2020,51(20):5220-5227.
[34]霍建霞,王嵘.扩张型心肌病患者CHRM3及抗体水平与临床特征的关系[J].山西医科大学学报,2019,50(11):1538-1542.
[35]WANG N,YAO M,XU J,et al.Autocrine Activation of CHRM3 Promotes Prostate Cancer Growth and Castration Resistance via CaM/CaMKK-Mediated Phosphorylation of Akt[J].Clin Cancer Res,2015,21(20):4676-85.
[36]Tate T,XIANG T,Wobker S E,et al.Pparg signaling controls bladder cancer subtype and immune exclusion[J].Nat Commun,2021,12(1):6160.
[37]Ahmadian M,Suh J M,Hah N,et al.PPARγ signaling and metabolism:the good,the bad and the future[J].Nat Med,2013,19(5):557-566.
[38]常金圆,李淏,江正龙,等.基于网络药理学探讨少腹逐瘀汤治疗癌性疼痛机制[J].中医学报,2021,36(11):2444-2449.
[39]Ameln H,Gustafsson T,Sundberg C J,et al.Physiological activation of hypoxia inducible factor-1 in human skeletal muscle[J].Faseb j,2005,19(8):1009-1011.
[40]KE Q,Costa M.Hypoxia-inducible factor-1 (HIF-1)[J].Mol Pharmacol,2006,70(5):1469-1480.
[41]Valle-tenney R,Rebolledo D,Acuňa M J,et al.HIF-hypoxia signaling in skeletal muscle physiology and fibrosis[J].J Cell Commun Signal,2020,14(2):147-158.
[42]宋亚琼,周播江.低氧诱导因子-1在调控骨骼肌缺氧时能量代谢发生适应性变化的机制研究进展[J].解剖学报,2017,48(2):236-240.
基本信息:
DOI:10.13412/j.cnki.zyyl.20240425.004
中图分类号:R285.5
引用信息:
[1]冉清智,何汶洋,李傲霜,等.基于网络药理学、分子对接和动物实验探究黄芪桂枝五物汤预防运动性疲劳的作用[J].中药药理与临床,2024,40(06):18-25.DOI:10.13412/j.cnki.zyyl.20240425.004.
基金信息:
中央高水平中医医院临床科研业务费(编号:HLCMHPP2023077); 中国中医科学院广安门医院续航人才工程青年拔尖人才培养项目(编号:CZ40909);中国中医科学院科技创新工程重大攻关项目(编号:CI2021A05011);中国中医科学院科技创新工程创新团队项目(编号:CI2021B017-05); 国家自然科学基金(编号:82074396); 国家重点研发计划项目(编号:2019YFF0301704)
2024-04-26
2024-04-26
2024-04-26